Limbix (by BigHealth)
Evidence-based digital therapeutics for adolescent mental health and behavioral activation.
Accelerating clinical trials by matching complex patient profiles to protocols in real-time using AI-driven EHR analysis.
Deep 6 AI is a sophisticated clinical trial acceleration platform that leverages advanced Natural Language Processing (NLP) to mine unstructured clinical data within Electronic Health Records (EHRs). Unlike traditional keyword-based searches, Deep 6 AI's engine understands clinical concepts, symptoms, and diagnoses found in physician notes, pathology reports, and genomics data. By 2026, the platform has solidified its position as a critical infrastructure layer connecting life sciences companies with health systems. Its technical architecture focuses on a proprietary 'AI-driven patient matching' engine that processes massive datasets to identify eligible participants for complex trials—especially in oncology and rare diseases—within minutes rather than months. The platform creates a collaborative ecosystem where sponsors can query real-time, de-identified patient populations across a network of research sites to validate protocol feasibility and accelerate recruitment. Positioned at the intersection of precision medicine and digital health, Deep 6 AI minimizes the 'last mile' problem in clinical research by automating the identification and validation of high-intent candidates, significantly reducing trial timelines and operational overhead for research coordinators.
Uses deep learning models to extract clinical entities from physician notes, imaging reports, and discharge summaries with high precision.
Evidence-based digital therapeutics for adolescent mental health and behavioral activation.
Predictive clinical and operational intelligence to fight death and waste in healthcare.
Predictive medical data and clinical insights for streamlined enterprise underwriting.
The professional medical network for clinicians, providing HIPAA-compliant AI and telehealth solutions.
Verified feedback from the global deployment network.
Post queries, share implementation strategies, and help other users.
Continuous monitoring of EHR updates to flag new patients who meet protocol criteria immediately as their data is entered.
Integrates genomic biomarkers and molecular data into the search criteria for precision medicine trials.
A secure portal allowing sponsors and sites to communicate regarding protocol feasibility without compromising patient privacy.
Automatically generates pre-populated screening forms highlighting why a patient matches specific inclusion/exclusion criteria.
Allows for querying population-level data for trial design without accessing PHI.
Compatible with Epic, Cerner, Meditech, and other major EHR systems using FHIR and proprietary connectors.
Oncology trials often have highly specific genetic and histological requirements that are buried in pathology PDFs.
Registry Updated:2/7/2026
Patients are contacted within 48 hours of diagnosis.
Sponsors often design protocols with criteria that are too restrictive, leading to zero-enrollment sites.
Finding patients with ultra-rare conditions who may be misdiagnosed or hidden in unstructured notes.